Viyash Scientific Limited (BOM:512529)

Market Cap	110.21B +151.4%
Revenue (ttm)	35.75B +123.1%
Net Income	2.11B +612.1%
EPS	4.75 +313.3%
Shares Out	436.46M
PE Ratio	53.18
Forward PE	27.41
Dividend	n/a
Ex-Dividend Date	n/a

Volume	107,550
Open	254.90
Previous Close	255.60
Day's Range	245.30 - 254.90
52-Week Range	167.50 - 297.90
Beta	0.97
Analysts	Strong Buy
Price Target	322.25 (+27.62%)
Earnings Date	Aug 11, 2026

About Viyash Scientific

Viyash Scientific Limited operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally. The company provides active pharmaceutical ingredients, finished dosage formulations, analytical services, and VET formulation services for cattle and poultry. The company was formerly known as Sequent Scientific Limited and changed its name to Viyash Scientific Limited in January 2026. The company was incorporated in 1985 and is headquartered in Hyderabad, India. Viyash Scientific Limited operates as a subsidiary o...

• Industry: Pharmaceutical Preparations
• Founded: 1985
• Employees: 2,900
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 512529

Financial Performance

In fiscal year 2026, Viyash Scientific's revenue was 34.20 billion, an increase of 13.75% compared to the previous year's 30.07 billion. Earnings were 1.77 billion, an increase of 663.53%.

Analyst Summary

According to 4 analysts, the average rating for 512529 stock is "Strong Buy." The 12-month stock price target is ₹322.25, which is an increase of 27.62% from the latest price.

Price Target

₹322.25

(27.62% upside)

Analyst Consensus: Strong Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 17, 2026

Data Sources Report a data error